O Ano de IPO de China Touyun Tech Group Limited é 2000
A oferta pública inicia (OPI)l é um tipo de oferta pública em que as ações de uma empresa geralmente são vendidas a investidores institucionais que, por sua vez, vendem para o público em geral, em uma bolsa de valores, pela primeira vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Touyun Biotech Group Limited, an investment holding company, designs, develops, manufactures, and sells packaging products in Hong Kong, the People's Republic of China, Europe, North and South America, and internationally. It operates through four segments: QR Code Business, Packaging Products, Treasury Investment, and Chlamydomonas Reinhardtii Product Business. The QR Code Business segment provides QR codes on product packaging and solutions; and online advertising display services. The Packaging Products segment manufactures and sells watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units. The Treasury Investment segment invests in and trades in securities, as well as offers money lending, securities brokerage, asset management, and margin financing services. The Chlamydomonas Reinhardtii Product Business segment produces and sells chlamydomonas reinhardtii, micro-algae, and related products. It also provides business intelligence IT solutions and corporate management services. The company was formerly known as China Touyun Tech Group Limited and changed its name to Touyun Biotech Group Limited in May 2021. Touyun Biotech Group Limited was founded in 1989 and is headquartered in Wan Chai, Hong Kong.